On Trapped Air and Trapped Blood in Chronic Obstructive Pulmonary Disease

od Watz, Henrik
Izdano u Am J Respir Crit Care Med (2019)

Sarcoidosis with involvement of the paranasal sinuses - a retrospective analysis of 12 biopsy-proven cases

od Kirsten, Anne-Marie, Watz, Henrik, Kirsten, Detlef
Izdano 2013

Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover st...

od Watz, Henrik, Mailänder, Claudia, Baier, Monika, Kirsten, Anne
Izdano u BMC Pulm Med (2016)

NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma

od Uddin, Mohib, Watz, Henrik, Malmgren, Anna, Pedersen, Frauke
Izdano u Front Immunol (2019)

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-co...

od Watz, Henrik, Krippner, Felix, Kirsten, Anne, Magnussen, Helgo, Vogelmeier, Claus
Izdano 2014

COPD: the patient perspective

od Jones, Paul W, Watz, Henrik, Wouters, Emiel FM, Cazzola, Mario
Izdano u Int J Chron Obstruct Pulmon Dis (2016)

Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Di...

od Facius, Axel, Marostica, Eleonora, Gardiner, Philip, Watz, Henrik, Lahu, Gezim
Izdano u Clin Pharmacokinet (2018)

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

od Watz, Henrik, Rickard, Kathleen, Rheault, Tara, Bengtsson, Thomas, Singh, Dave
Izdano u Int J Chron Obstruct Pulmon Dis (2020)

A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD

od Singh, Dave, Martinez, Fernando J., Watz, Henrik, Bengtsson, Thomas, Maurer, Brian T.
Izdano u Respir Res (2020)

Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone

od Balint, Beatrix, Watz, Henrik, Amos, Carolynn, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Izdano 2010

Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression

od Andreas, Stefan, Röver, Christian, Heinz, Judith, Straube, Sebastian, Watz, Henrik, Friede, Tim
Izdano u Respir Res (2019)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline

od Ferguson, Gary T, Shaikh, Asif, Tetzlaff, Kay, Mueller, Achim, Magnussen, Helgo, Watz, Henrik
Izdano u Int J Chron Obstruct Pulmon Dis (2020)

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD

od Holz, Olaf, Roepcke, Stefan, Watz, Henrik, Tegtbur, Uwe, Lahu, Gezim, Hohlfeld, Jens M
Izdano u Int J Chron Obstruct Pulmon Dis (2015)

Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study

od Harbaum, Lars, Hennigs, Jan K., Simon, Marcel, Oqueka, Tim, Watz, Henrik, Klose, Hans
Izdano u Respir Res (2021)

Lymphangioleiomyomatosis—presence of receptor tyrosine kinases and the angiogenesis factor VEGF‐A as potential therapeutic targets

od Watz*, Henrik, Engels*, Knut, Loeschke, Siegfried, Amthor, Michael, Kirsten, Detlef, Magnussen, Helgo, Magnussen, Helgo
Izdano 2007

Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD

od Holz, Olaf, Waschki, Benjamin, Roepcke, Stefan, Watz, Henrik, Lauer, Gereon, Faulenbach, Cornelia, Hohlfeld, Jens M
Izdano 2014

Rating sputum cell quality in clinical trials for asthma and COPD treatment

od Pedersen, Frauke, Zissler, Ulrich M, Watz, Henrik, Rabe, Klaus F, Hohlfeld, Jens M, Holz, Olaf
Izdano u Int J Chron Obstruct Pulmon Dis (2019)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

od Waschki, Benjamin, Watz, Henrik, Holz, Olaf, Magnussen, Helgo, Olejnicka, Beata, Welte, Tobias, Rabe, Klaus F, Janciauskiene, Sabina
Izdano u Int J Chron Obstruct Pulmon Dis (2017)

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat(®) device for maintenance treatment of COPD: comparison with the long-acting β(2)-agonist formoterol

od Koch, Andrea, Watz, Henrik, Maleki-Yazdi, M. Reza, Bothner, Ulrich, Tetzlaff, Kay, Voß, Florian, McGarvey, Lorcan
Izdano u NPJ Prim Care Respir Med (2017)

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

od Goldmann, Torsten, Zissel, Gernot, Watz, Henrik, Drömann, Daniel, Reck, Martin, Kugler, Christian, Rabe, Klaus F., Marwitz, Sebastian
Izdano u Respir Res (2018)